NEW YORK / Apr 09, 2025 / Business Wire / Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025.
Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows:
Live Call: 1.855.761.5600
Conference ID: 7768132
Webcast
The call will be archived and available on Oscar’s investor relations website (ir.hioscar.com) following May 7, 2025 for a period of 90 days.
About Oscar Health
Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.8 million members, as of February 1, 2025.
Last Trade: | US$20.51 |
Daily Change: | -0.16 -0.77 |
Daily Volume: | 11,199,893 |
Market Cap: | US$4.570B |
September 15, 2025 August 06, 2025 July 22, 2025 May 07, 2025 February 04, 2025 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load